Levosimendan
Drug timelines are a Plus or Pro feature.
74 regulatory and trial events tracked for Levosimendan, covering 2006-12-15 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients [Phase 2]